Viewing Study NCT00890903

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:24 PM
Ignite Modification Date: 2026-05-18 @ 6:02 AM
Study NCT ID: NCT00890903
Status: COMPLETED
Last Update Posted: 2012-07-02
First Post: 2009-04-29
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Non-Interventional Study With Vinorelbine ORAL in Advanced Non-Small Cell Lung Carcinoma(NSCLC) and Metastatic Breast Cancer (MBC)
Sponsor: Pierre Fabre Pharma GmbH
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non Small Cell Lung Carcinoma View
None Metastatic Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None NSCLC View
None non small cell lung carcinoma View
None metastatic breast cancer View
None MBC View
None advanced breast cancer View
None Navelbine View
None Navelbine-ORAL View
None Vinorelbine View
None Vinorelbine-ORAL View
None daily routine View
None concomitant antiemetic therapy View
None patient compliance View
None germany View
None non-interventional study View
None oral anti cancer therapy View
None quality of life View